Candidalysin Is the Hemolytic Factor of Candida albicans

Candida albicans produces an important virulence factor, the hypha-associated Ece1-derived secreted peptide toxin candidalysin, which is crucial for the establishment of mucosal and systemic infections. C. albicans has also long been known to be hemolytic, yet the hemolytic factor has not been clearly identified. Here, we show that candidalysin is the hemolytic factor of C. albicans. Its hemolytic activity is modulated by fragments of another Ece1 peptide, P7. Hemolysis by candidalysin can be neutralized by the purinergic receptor antagonist pyridoxal-phosphate-6-azophenyl-2′,4′-disulfonic acid (PPADS). PPADS also affects candidalysin’s ability to intercalate into synthetic membranes. We also describe the neutralization potential of two anti-candidalysin nanobodies, which are promising candidates for future anti-Candida therapy. This work provides evidence that the historically proposed hemolytic factor of C. albicans is in fact candidalysin and sheds more light on the complex roles of this toxin in C. albicans biology and pathogenicity.

[1]  L. Migliolo,et al.  Evaluation of a Novel Synthetic Peptide Derived from Cytolytic Mycotoxin Candidalysin , 2022, Toxins.

[2]  S. Brunke,et al.  Candidalysin delivery to the invasion pocket is critical for host epithelial damage induced by Candida albicans , 2021, Cellular Microbiology.

[3]  N. Németh,et al.  In vitro effects of temperature on red blood cell deformability and membrane stability in human and various vertebrate species. , 2021, Clinical hemorheology and microcirculation.

[4]  D. Kornitzer,et al.  Pathways of heme utilization in fungi. , 2020, Biochimica et biophysica acta. Molecular cell research.

[5]  C. Murdoch,et al.  Candidalysin Is Required for Neutrophil Recruitment and Virulence During Systemic Candida albicans Infection , 2019, The Journal of infectious diseases.

[6]  T. Hohl,et al.  CARD9+ Microglia Promote Antifungal Immunity via IL-1β and CXCL1-mediated Neutrophil Recruitment , 2019, Nature Immunology.

[7]  P. Koenig,et al.  The fungal peptide toxin Candidalysin activates the NLRP3 inflammasome and causes cytolysis in mononuclear phagocytes , 2018, Nature Communications.

[8]  M. Schaller,et al.  Candida albicans-Induced Epithelial Damage Mediates Translocation through Intestinal Barriers , 2018, mBio.

[9]  S. Gaffen,et al.  Processing of Candida albicans Ece1p Is Critical for Candidalysin Maturation and Fungal Virulence , 2018, mBio.

[10]  K. Barker,et al.  Candidalysin Drives Epithelial Signaling, Neutrophil Recruitment, and Immunopathology at the Vaginal Mucosa , 2017, Infection and Immunity.

[11]  N. Hellmann,et al.  P2X-Receptor Antagonists Inhibit the Interaction of S. aureus Hemolysin A with Membranes , 2017, Toxins.

[12]  E. Cota,et al.  Candidalysin is a fungal peptide toxin critical for mucosal infection , 2016, Nature.

[13]  M. Penatti,et al.  Enzymatic and hemolytic activity in different Candida species. , 2015, Revista iberoamericana de micologia.

[14]  M. Lenardo,et al.  Divalent cation signaling in immune cells. , 2014, Trends in immunology.

[15]  J. C. Junqueira,et al.  Comparison of the hemolytic activity between C. albicans and non-albicans Candida species. , 2013, Brazilian oral research.

[16]  M. Ueda,et al.  Secreted aspartic peptidases of Candida albicans liberate bactericidal hemocidins from human hemoglobin , 2013, Peptides.

[17]  S. Brunke,et al.  A Core Filamentation Response Network in Candida albicans Is Restricted to Eight Genes , 2013, PloS one.

[18]  H. Praetorius,et al.  Haemolysis induced by α-toxin from Staphylococcus aureus requires P2X receptor activation , 2011, Pflügers Archiv - European Journal of Physiology.

[19]  C. Pérez-Giraldo,et al.  Aspartyl proteinase, phospholipase, hemolytic activities and biofilm production of Candida albicans isolated from bronchial aspirates of ICU patients. , 2011, Medical mycology.

[20]  N. Jørgensen,et al.  α-Hemolysin from Escherichia coli uses endogenous amplification through P2X receptor activation to induce hemolysis , 2009, Proceedings of the National Academy of Sciences.

[21]  Scott G. Filler,et al.  The Hyphal-Associated Adhesin and Invasin Als3 of Candida albicans Mediates Iron Acquisition from Host Ferritin , 2008, PLoS pathogens.

[22]  Bernhard Hube,et al.  Processing of predicted substrates of fungal Kex2 proteinases from Candida albicans, C. glabrata, Saccharomyces cerevisiae and Pichia pastoris , 2008, BMC Microbiology.

[23]  P. Mak.  Hemocidins in a functional and structural context of human antimicrobial peptides. , 2008, Frontiers in bioscience : a journal and virtual library.

[24]  Martin Schaller,et al.  In vivo transcript profiling of Candida albicans identifies a gene essential for interepithelial dissemination , 2007, Cellular microbiology.

[25]  D. Roberts,et al.  Hemoglobin is an effective inducer of hyphal differentiation in Candida albicans. , 2007, Medical mycology.

[26]  M. Pfaller,et al.  Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem , 2007, Clinical Microbiology Reviews.

[27]  D. Diogo,et al.  Multilocus Sequence Typing Reveals Intrafamilial Transmission and Microevolutions of Candida albicans Isolates from the Human Digestive Tract , 2006, Journal of Clinical Microbiology.

[28]  W. Nedel,et al.  Risk factors and outcome for nosocomial breakthrough candidaemia. , 2006, The Journal of infection.

[29]  J. Schwartz,et al.  Protease Inhibitors Fail To Prevent Pore Formation by the Activated Bacillus thuringiensis Toxin Cry1Aa in Insect Brush Border Membrane Vesicles , 2006, Applied and Environmental Microbiology.

[30]  Rebecca Buxton.  Blood Agar Plates and Hemolysis Protocols , 2005 .

[31]  P. Mak,et al.  Antibacterial hemoglobin peptides in human menstrual blood , 2004, Peptides.

[32]  W. Seeger,et al.  The hemolysin of escherichia coli , 1988, European Journal of Epidemiology.

[33]  M. Murakami,et al.  Characterization of a haemolytic factor from Candida albicans. , 1999, Microbiology.

[34]  T. Mikami,et al.  Hemoglobin is utilized by Candida albicans in the hyphal form but not yeast form. , 1997, Biochemical and biophysical research communications.

[35]  R. Rappuoli,et al.  Low pH Activates the Vacuolating Toxin of Helicobacter pylori, Which Becomes Acid and Pepsin Resistant (*) , 1995, The Journal of Biological Chemistry.

[36]  D. Mosser,et al.  Production of a hemolytic factor by Candida albicans , 1994, Infection and immunity.

[37]  C. Birse,et al.  Cloning and characterization of ECE1, a gene expressed in association with cell elongation of the dimorphic pathogen Candida albicans , 1993, Infection and immunity.

[38]  D. Mosser,et al.  A role for complement receptor-like molecules in iron acquisition by Candida albicans , 1992, The Journal of experimental medicine.

[39]  S. Bhakdi,et al.  Alpha-toxin of Staphylococcus aureus , 1991 .

[40]  K. Shortman,et al.  The Effect of pH on the Volume, Density and Shape of Erythrocytes and Thymic Lymphocytes * , 1968, British journal of haematology.

[41]  M. Kuprowski.  The influence of the quality of agar on the occurrence of haemolysis in cultures of Candida albicans. , 2010, Zentralblatt fur Veterinarmedizin. Reihe B. Journal of veterinary medicine. Series B.

[42]  S. Salvin.  Hemolysin from the Yeastlike Phases of Some Pathogenic Fungi , 1951, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.